Related Experiment Video
Updated: Jun 15, 2026
07:01
Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools
Published on: August 19, 2025
[Comparative proteomic analysis of human gallbladder carcinoma]
Yi Tan1, Hai-ping Meng, Fu-qiang Wang
1Department of General Surgery, The Second Hospital Affiliated to Soochow University, Jiangsu, Suzhou 215004, China.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|March 10, 2010
Summary
Proteomic analysis identified seventeen differentially expressed proteins in gallbladder carcinoma tissues compared to benign tissues. These findings offer potential molecular targets for improved diagnosis, treatment, and understanding of gallbladder cancer.
Area of Science:
- Oncology
- Proteomics
- Biochemistry
Background:
- Gallbladder carcinoma is a significant health concern with limited diagnostic and therapeutic options.
- Identifying specific molecular targets is crucial for advancing gallbladder cancer management.
Purpose of the Study:
- To identify potential molecular targets for gallbladder carcinoma diagnosis and treatment.
- To compare protein expression profiles between cancerous and benign gallbladder tissues.
Main Methods:
- Proteomic analysis using two-dimensional gel electrophoresis (2-DE) on 6 human gallbladder carcinoma and 6 benign tissues.
- Identification of differentially expressed proteins via matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF-MS).
- Immunohistochemistry to validate the expression of PEBP1 protein in independent samples.
Main Results:
- Forty-six differentially expressed proteins were detected in gallbladder carcinoma tissues.
- Seventeen proteins were successfully identified; nine were overexpressed and eight were underexpressed in tumors.
- Increased PEBP1 protein levels in gallbladder carcinoma were confirmed by immunohistochemistry.
Conclusions:
- Comparative proteomic analysis successfully characterized seventeen differentially expressed proteins.
- These proteins may serve as molecular biomarkers for gallbladder carcinoma diagnosis and treatment.
- The findings provide a foundation for improving prognosis and understanding gallbladder cancer carcinogenesis.
